|
US3854480A
(en)
|
1969-04-01 |
1974-12-17 |
Alza Corp |
Drug-delivery system
|
|
US3832253A
(en)
|
1973-03-21 |
1974-08-27 |
Baxter Laboratories Inc |
Method of making an inflatable balloon catheter
|
|
US4667014A
(en)
|
1983-03-07 |
1987-05-19 |
Syntex (U.S.A.) Inc. |
Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
|
|
US4452775A
(en)
|
1982-12-03 |
1984-06-05 |
Syntex (U.S.A.) Inc. |
Cholesterol matrix delivery system for sustained release of macromolecules
|
|
CA1200416A
(en)
|
1983-05-13 |
1986-02-11 |
Societe Des Produits Nestle S.A. |
Food process
|
|
GB8518144D0
(en)
|
1985-07-18 |
1985-08-21 |
Univ Belfast |
Solid phase peptide synthesis
|
|
US5075109A
(en)
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
|
US4794150A
(en)
|
1987-03-11 |
1988-12-27 |
Samuel Steel |
Synthesis of peptide analogs
|
|
US5541297A
(en)
|
1988-04-01 |
1996-07-30 |
Immunomedics, Inc. |
Therapeutic conjugates of toxins and drugs
|
|
US5180816A
(en)
|
1988-08-24 |
1993-01-19 |
Centocor |
One vial method for labeling protein/linker conjugates with technetium-99M
|
|
US5221754A
(en)
|
1989-06-09 |
1993-06-22 |
Research Corporation Technologies, Inc. |
Reagents for rapid peptide synthesis
|
|
US5766897A
(en)
|
1990-06-21 |
1998-06-16 |
Incyte Pharmaceuticals, Inc. |
Cysteine-pegylated proteins
|
|
JPH04167172A
(ja)
|
1990-10-31 |
1992-06-15 |
Nec Corp |
ベクトルプロセッサ
|
|
US5565332A
(en)
|
1991-09-23 |
1996-10-15 |
Medical Research Council |
Production of chimeric antibodies - a combinatorial approach
|
|
AU5670194A
(en)
|
1992-11-20 |
1994-06-22 |
Enzon, Inc. |
Linker for linked fusion polypeptides
|
|
WO1995001368A1
(en)
|
1993-06-29 |
1995-01-12 |
Ferring B.V. |
Improved synthesis of cyclic peptides
|
|
US5571787A
(en)
|
1993-07-30 |
1996-11-05 |
Myelos Corporation |
Prosaposin as a neurotrophic factor
|
|
US5700909A
(en)
|
1993-07-30 |
1997-12-23 |
The Regents Of The University Of California |
Prosaposin and cytokine-derived peptides
|
|
US5552471A
(en)
|
1994-08-17 |
1996-09-03 |
The Perkin-Elmer Corporation |
Solid support reagents for the synthesis of 3'-Nitrogen containing polynucleotides
|
|
US6001966A
(en)
|
1995-10-19 |
1999-12-14 |
Proligo Llc |
Method for solution phase synthesis of oligonucleotides and peptides
|
|
US5817752A
(en)
|
1996-06-06 |
1998-10-06 |
La Jolla Pharmaceutical Company |
Cyclic polypeptides comprising a thioether linkage and methods for their preparation
|
|
US7176282B1
(en)
|
1996-09-09 |
2007-02-13 |
Zealand Pharma A/S |
Solid-phase peptide synthesis and agent for use in such synthesis
|
|
EP1011709A4
(en)
|
1997-09-09 |
2003-06-18 |
Univ California |
INHIBITION OF APOPTOSIS USING PROSAPOSIN RECEPTOR AGONISTS
|
|
DE69921102T2
(de)
|
1998-03-05 |
2006-02-02 |
Chiron Corp., Emeryville |
Verfahren zur verbesserung der serum-halbwertszeit von biologisch aktiven molekülen
|
|
US7094943B2
(en)
|
1998-04-27 |
2006-08-22 |
Hubert Köster |
Solution phase biopolymer synthesis
|
|
US6638911B1
(en)
*
|
1998-05-05 |
2003-10-28 |
Adherex Technologies Inc. |
Compounds and methods for modulating desmosomal cadherin-mediated functions
|
|
US7341730B1
(en)
|
1998-07-13 |
2008-03-11 |
University Of Southern California |
Inhibitors of angiogenesis and tumor growth
|
|
AUPP616498A0
(en)
|
1998-09-25 |
1998-10-15 |
University Of Queensland, The |
Synthesis of cyclic peptides
|
|
US6706252B1
(en)
|
1998-10-30 |
2004-03-16 |
Rx/Ibr Corporation |
Method of treating disease with radioisotopes conjugated to bioactive substances
|
|
US20020177551A1
(en)
|
2000-05-31 |
2002-11-28 |
Terman David S. |
Compositions and methods for treatment of neoplastic disease
|
|
US20020168639A1
(en)
|
2000-09-22 |
2002-11-14 |
Muraca Patrick J. |
Profile array substrates
|
|
AU9558901A
(en)
|
2000-10-05 |
2002-04-15 |
Ares Trading Sa |
Regioselective liquid phase pegylation
|
|
WO2003102018A2
(en)
|
2002-06-03 |
2003-12-11 |
The Institute For Systems Biology |
Methods for quantitative proteome analysis of glycoproteins
|
|
US20040219609A1
(en)
|
2002-07-12 |
2004-11-04 |
Day Anthony G. |
Methods for modulating proteins not previously known as proteases
|
|
US7166691B2
(en)
|
2002-12-20 |
2007-01-23 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Saposin C and receptors as targets for treatment of benign and malignant disorders
|
|
WO2004084930A1
(en)
|
2003-03-26 |
2004-10-07 |
Develogen Aktiengesellschaft |
Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome
|
|
US7610156B2
(en)
|
2003-03-31 |
2009-10-27 |
Xencor, Inc. |
Methods for rational pegylation of proteins
|
|
US7834147B2
(en)
|
2003-04-28 |
2010-11-16 |
Childrens Hospital Medical Center |
Saposin C-DOPS: a novel anti-tumor agent
|
|
GB0318205D0
(en)
|
2003-08-02 |
2003-09-03 |
Albachem Ltd |
Synthetic method
|
|
WO2006119035A2
(en)
|
2005-04-29 |
2006-11-09 |
(Osi) Eyetech, Inc. |
Vegf variants
|
|
US20070099251A1
(en)
|
2005-10-17 |
2007-05-03 |
Institute For Systems Biology |
Tissue-and serum-derived glycoproteins and methods of their use
|
|
US20080090760A2
(en)
|
2005-12-09 |
2008-04-17 |
Todd Hembrough |
Compositions and Methods for Inhibiting Cellular Proliferation
|
|
EP2125862A1
(en)
|
2006-12-29 |
2009-12-02 |
F. Hoffmann-Roche AG |
Methods for the synthesis of cyclic peptides
|
|
EP3127549B1
(en)
*
|
2007-06-22 |
2019-12-18 |
Children's Medical Center Corporation |
Methods and uses thereof of a fragment of saposin a
|
|
US8027291B2
(en)
|
2007-09-27 |
2011-09-27 |
Wireless Technology Solutions Llc |
Method and apparatus for transmitting transport channels over a physical channel of a cellular communication system
|
|
JP6063626B2
(ja)
|
2008-07-28 |
2017-01-18 |
チルドレンズ メディカル センター コーポレーション |
プロミニン−１ペプチド断片およびその使用
|
|
EP2513137B1
(en)
|
2009-12-17 |
2018-02-28 |
Children's Medical Center Corporation |
Saposin-a derived peptides and uses thereof
|
|
CA2860226C
(en)
|
2011-12-22 |
2022-10-18 |
Randolph S. Watnick |
Saposin-a derived peptides and uses thereof
|
|
EP3919070B1
(en)
|
2013-03-14 |
2024-10-16 |
Children's Medical Center Corporation |
Use of cd36 to identify cancer subjects for treatment by a psap peptide
|
|
JP6727129B2
(ja)
|
2014-03-26 |
2020-07-22 |
ザ チルドレンズ メディカル センター コーポレーション |
環状プロサポシンペプチドおよびその使用
|